## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no full text, figures, tables, or supplementary materials were provided
- **Shared manuscript claim summary** The authors propose MsPBRsP, a tool-free end-to-end deep learning framework using the ProtTrans language model and multi-scale attention and convolutional windows, to predict protein binding residues (PBRs) across multiple interaction types. They claim superior performance over state-of-the-art methods on several benchmark datasets, with specific F1 and AUPRC improvements on NSP448 and a large reduction in running time.
- **Visible evidence base** Abstract text only; no dataset descriptions, model architecture details, hyperparameters, statistical tests, or benchmark comparisons are available
- **Missing materials affecting confidence** Full manuscript, all figures and tables, dataset specifications, baseline method details, evaluation protocols, and code verification are not provided

## Reviewer
- **Overall assessment** The abstract presents a potentially useful contribution to protein binding residue prediction by addressing two known limitations in existing methods, namely dependence on slow MSA tools and uncertainty in choosing residue context scales. The use of a pre-trained language model and multi-scale architecture is conceptually reasonable. However, the abstract alone does not provide sufficient evidence to evaluate the validity of the performance claims, the rigor of the experimental design, or the generalizability of the framework. The reported improvements are large and would require careful verification of dataset splits, baseline fairness, and statistical significance.
- **Who would be interested in the results, and why** Computational biologists and bioinformaticians working on protein function annotation, drug design, and protein interaction prediction would be interested. Researchers developing deep learning methods for biological sequence analysis, particularly those exploring language model applications, would also find the approach relevant. The claim of fast, tool-free prediction could appeal to those needing high-throughput screening.
- **Major strengths** The problem addressed is important and timely. The proposed framework directly targets practical limitations of existing methods, namely computational cost and scale selection. The use of a pre-trained language model is a modern and promising direction. The claim of applicability to multiple PBR types is ambitious and, if validated, would be a significant advance.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
- **Technical failings that need to be addressed before the case is established** The abstract does not provide any details on dataset construction, evaluation protocol, baseline implementations, or statistical testing. Without these, the reported performance improvements cannot be independently assessed. The claim of "superior performance" on every task is not supported by any comparative data in the abstract.
- **Assessment against Nature-style criteria** Originality is moderate, as the combination of language models and multi-scale architectures is not entirely novel, though the specific application to multiple PBR types may be. Scientific importance is potentially high if the claims hold, but the evidence base is insufficient to judge. Interdisciplinary readership is plausible given the intersection of machine learning and structural biology. Technical soundness cannot be evaluated from the abstract alone. Readability for nonspecialists is adequate, though some terms such as "multi-size windows" and "multi-size kernels" are not fully explained.
- **Recommendation posture** Currently not established from the provided evidence. The abstract is promising but lacks the necessary detail to support the strong performance claims. A full manuscript with rigorous experimental validation would be required to assess the case.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Evidence sufficiency
- **Claim pointer** The authors claim "superior performance with less running time and higher prediction rates on every PBRs prediction task" and specifically report F1 improvement of 27.1% and AUPRC improvement of 7.6% on NSP448.
- **Evidence pointer** Abstract only; no figures, tables, or dataset descriptions provided
- **Concern** The abstract provides no comparative data, baseline descriptions, or statistical analysis to support the claimed performance improvements. The magnitude of the F1 improvement is unusually large and could indicate differences in evaluation protocols, dataset splits, or baseline implementations rather than genuine model superiority.
- **Why it matters** Without a clear description of the evaluation setup, the reported numbers cannot be reproduced or verified. The claim of universal superiority across all tasks is particularly strong and requires comprehensive benchmarking evidence.
- **Resolution test** Provide full experimental details including dataset splits, baseline versions, hyperparameters, and statistical significance tests. Show performance tables for all datasets and all compared methods.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Methodological clarity
- **Claim pointer** The authors state they "construct multi-size windows in attention layer and multi-size kernels in convolutional layer" to address scale uncertainty.
- **Evidence pointer** Abstract only; no architecture diagram or layer specifications provided
- **Concern** The abstract does not explain how the multi-scale mechanism works, how many scales are used, or how they are integrated. It is unclear whether the model learns the optimal scale or simply concatenates features from fixed scales. The relationship between the attention and convolutional components is also unspecified.
- **Why it matters** The core methodological contribution is the multi-scale design. Without a clear description, the novelty and technical soundness cannot be assessed, and the approach cannot be replicated.
- **Resolution test** Provide a detailed model architecture description, including the number and size of windows and kernels, how they are combined, and any ablation studies showing the contribution of each component.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Generalizability and dataset coverage
- **Claim pointer** The authors claim the framework "can be applied to all types of PBRs" and test on datasets from protein-protein, protein-nucleotide, protein-small ligand, heterodimer, homodimer, and antibody-antigen interactions.
- **Evidence pointer** Abstract only; no dataset sizes, class distributions, or sequence diversity information provided
- **Concern** The abstract lists six interaction types but provides no details on the number of proteins, residues, or binding sites in each dataset. It is unclear whether the datasets are balanced, how redundancy is handled, and whether the model performance is consistent across all types or driven by a subset.
- **Why it matters** The claim of universal applicability is central to the paper's significance. Without dataset characterization, the reader cannot judge whether the framework generalizes or overfits to specific interaction types.
- **Resolution test** Provide dataset statistics, redundancy reduction procedures, and per-dataset performance breakdowns. Show that the model performs well across all interaction types, not just a few.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity of terminology
- **Affected element** "tool-free" and "end-to-end" descriptors
- **Evidence pointer** Abstract, first paragraph
- **Issue** The term "tool-free" is ambiguous. It likely means no external MSA tools are required, but it could be interpreted as no external tools at all, which is not accurate since ProtTrans is a pre-trained model.
- **Required correction** Clarify that "tool-free" refers specifically to the absence of MSA generation tools, and specify that ProtTrans is used as a pre-trained component.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Reproducibility
- **Affected element** Running time comparison
- **Evidence pointer** Abstract, last sentence
- **Issue** The running time comparison from "over 10 minutes to under 0.1s" lacks context. It is unclear what hardware was used, whether the comparison is per protein or per dataset, and whether the baseline time includes MSA generation.
- **Required correction** Specify the hardware, the unit of measurement, and the exact baseline method and its configuration for the time comparison.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Statistical rigor
- **Affected element** Performance metrics
- **Evidence pointer** Abstract, last sentence
- **Issue** The abstract reports F1 and AUPRC improvements but does not mention standard deviations, confidence intervals, or significance tests. Single-point improvements are not sufficient to establish reliability.
- **Required correction** Report mean and standard deviation across multiple runs, and include statistical significance tests where appropriate.

## Risk / unsupported claims
- The claim of "superior performance on every PBRs prediction task" is unsupported by any comparative data in the abstract.
- The specific F1 improvement of 27.1% and AUPRC improvement of 7.6% on NSP448 are not verifiable without dataset and baseline details.
- The claim of "general tool-free end-to-end framework" is partially unsupported because the role of ProtTrans as a pre-trained model is not fully clarified.
- The applicability to "all types of PBRs" is not supported by dataset descriptions or per-type performance evidence.
- The running time reduction claim is not contextualized with hardware or measurement details.